Publication | Closed Access
A Pilot Controlled Clinical Trial of ABT-418, a Cholinergic Agonist, in the Treatment of Adults With Attention Deficit Hyperactivity Disorder
229
Citations
45
References
1999
Year
The results of this investigation indicate that ABT-418, a nicotinic analog, may be a potentially useful agent for the treatment of ADHD.
| Year | Citations | |
|---|---|---|
Page 1
Page 1